May 2008: Tailor treatment to the patient with migraine
21 May 2008
Migraine is a common, disabling primary headache disorder. it affects 15% of the UK population (7.6% of men and 19.1% of women) and is especially prevalent in patients <50 years. It contributes to 25 million lost work or schooldays every year.1 Migraine is a chronic disease with episodic manifestations. The natural history tends to follow a waxing and waning course, with patients experiencing phases of infrequent attacks and/or chronic headaches interspersed with attack-free remissions.2 Migraine can be classified into two major subtypes, with and without aura, occurring in 20-30% and 70-80% of cases, respectively.Other clinically important variants include chronic migraine, basilar and hemiplegic migraine, migraine in pregnancy and menstrual migraine.
This article can be accessed only if you are a paid-up subscriber to The Practitioner.
To subscribe contact: thepractitioner@servicehelpline.co.uk
Overseas subscription
Individual: £138Institutional: £138
Overseas: +44 (0)1795 418 670
Subscription enquiry: thepractitioner@servicehelpline.co.uk
UK subscription
Individual: £85Institutional: £85
UK: 0844 815 5934
Subscription enquiry: thepractitioner@servicehelpline.co.uk
= Registered users